Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Finance

Asset renaissance

How Medicxi increases Phase II successes with less capital

February 8, 2016 8:00 AM UTC

The former life sciences team from Index Ventures has set up shop as Medicxi Ventures with a heavily oversubscribed new fund, and an investment model that has so far scored it a 100% success rate in Phase II readouts while halving the capital needed to get there.

Medicxi is taking with it the 12-person life sciences team from Index, the remaining capital from the almost fully invested Index Ventures Life VI fund, and a portfolio of about 40 life sciences companies...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article